Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 136.00 135.00 137.00 0.00 0.00 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 165.6 8.4 6.3 21.7 144

Cello Health Share Discussion Threads

Showing 451 to 475 of 1075 messages
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older
DateSubjectAuthorDiscuss
02/12/2010
17:50
Interesting large buy today? Director?
santangello
12/11/2010
10:06
Another buy on PLUS....all encouraging stuff.....especially with todays market sell off
santangello
12/11/2010
10:06
Another buy on PLUS....all encouraging stuff.....especially with todays market sell off
santangello
10/11/2010
07:54
Yes, plenty of activity....and PLUS has been busy too. I would expect a move from theses levels, unless a big seller is in the background, which it doesn't look like. (Why the hell would you sell these??????)
santangello
09/11/2010
08:36
Steady buying in the last week. Not surprised with others in this sector reporting strong growth.
interceptor2
29/10/2010
06:46
Worth reading todays IMS from WPP, which has a very detailed account of performance from different world regions. They have seen very strong growth in UK, USA, Western Europe and of course emerging markets. I think the interesting part and significant to CLL is the strong growth in the Media sector in the UK, which CLL has large exposure too. Should be positive for CLL. imo. http://www.advfn.com/p.php?pid=nmona&article=44984625&symbol=LSE%3Awpp
interceptor2
28/10/2010
11:28
Cello recommended as a buy in Share mag today along with WPP and Toluna in a sector report. Sorry I cant tell more as not a subscriber. Regards......
interceptor2
27/10/2010
17:38
Thanks Santangello I had missed the RNS. As you say still very cheap, they almost join the party. But with a per of 6.3 and 6.2 and debt falling faster then predicted. It's just a matter of patience, and one more trading update before the market and other investors see the improvement here. Regards..........
interceptor2
27/10/2010
17:07
Nice to see a well respected trust fund (Ennismore) increasing its stake. Can see these rocket back to pre xd levels and beyond. A ridiculous rating at present, going forward......
santangello
14/10/2010
17:01
T traders bailing, that's all............ Good time to pick up, if you are an investor.
santangello
14/10/2010
14:19
I topped up plenty just before interims - and liked what I heard then. I especially like the low multiple (vs. Creston and Chime), the way they've paid down their debt, the strength in pharma and the plans to go for growth in the US. My hearing is good, though with limited range. I know people in a couple of the companies and both are saying that the second half is looking very big (at least in their specific parts of the group). It's far from the whole picture, but I'm sure there's good value to be had here.
coopstock
14/10/2010
13:36
someone wants out and its hopelessly illquid - quotes only good in 2k. MM's will be extracting their pound of flesh in the absence of any fresh buyers? I suggest if you hear thnigs are good you top up whilst stock lasts? How good is your hearing ? If its good I might add a few myself ! TIA
felix99
14/10/2010
11:11
Any ideas what's going on? Everything I hear from inside Cello is that the companies are all going gangbusters.
coopstock
21/9/2010
19:33
severance? Not me fella....lol You didn't did you????
santangello
21/9/2010
15:38
Interview with Mark Scott and Mark Bentley at Cello - http://www.stockopedia.co.uk/content/mark-scott-and-mark-bentley-of-cello-group-talk-to-stockopedia-48126/
yespmedc
21/9/2010
07:05
Cello still isn't a PR company. So why update a write-up comparing it to some PR companies? It was an ill-informed comparison then, and it still is now. And given AiW's recent track record, I'd have thought keeping him as far away from this company as possible would be the best thing for it.
lpf
20/9/2010
23:23
This would be a great post (two years ago) to update with the current day comparisons... http://boards.fool.co.uk/the-trouble-with-pr-11165427.aspx Amazing that the other share prices have doubled but Cello is still well below its two year ago price
davidosh
20/9/2010
23:04
Santa - hope you haven't spent all your severance dosh already??!!
jeff h
20/9/2010
19:12
Naughty tree shake today, naughty......tut tut. Hi Jeff, you OK buddy? Watching these closely along with one of your old faves TNO...... I have also added HVN and STF of late.....
santangello
19/9/2010
15:06
Rated a "Buy" by the IC on Friday.
jeff h
17/9/2010
20:17
Hybridan Cello Group (CLL 46p/£28.25m) Cello continues its impressive share price performance with a further rise of over 25 per cent since the end of July when we last commented on the Company. Today it announced its half year results showing headline ongoing operating profit up 25 per cent to £3.3m (2009: £2.6m), margins improved to 10.9 per cent (2009: 8.9 per cent) and net debt down to £11.7m (2009: £14.8m). The fall off in income from the public sector has not impacted materially the overall mix of business, with the top 20 clients from 2009 remaining significant revenue generators for the Company in 2010, with many increasing their levels of expenditure. The largest customer accounts for only 4.4 per cent of total income, with the top 20 customers for less than 40 per cent. The robust Pharmaceutical sector on the other hand now accounts for over 25 percent of the group's income. The Company thus appears to have created a secure and solid base from which to advance. On the results the CEO commented "We are now seeing a pick up from our clients in the private sector across a range of industries....(and) have started to carefully organically expand the business again". This positive statement, along with the small 5 percent increase in the interim dividend bodes well for investors who we expect to continue to support the progress of this growing company.
stegrego
17/9/2010
15:10
Singer Capital Markets is initiating coverage of market research and consulting group Cello with a positive recommendation, saying that most of the company's earn out obligations from previous takeovers are behind it and the company is in a position again to expand through acquisition. The company's recent interim results demonstrated a return to positive growth despite extreme near term headwinds in the public sector, which Singer rates as "an exceptionally strong performance in this context." The broker thinks there are three main reasons to buy the shares. First is the aforementioned revenue growth. "Acquisitions are back on the agenda and will enhance growth. Cello's biggest business segment, Healthcare, is driving growth and international expansion offsetting the short term public sector headwind," the broker said. Cello chief executive Mark Scott told Sharecast earlier this week that the company "will buy again, probably in America" and that the plan is to double the size of Cello in the next two or three years. The second reason to buy cited by Singer is the company's strong positions in market research and healthcare. These are "scarce assets in a consolidating market." The broker also believes the shares are undervalued because the earnings are in the low part of the cycle. Compared to the valuation of its peers, the stock is cheap, and Singer thinks it is also undervalued on a sum of the parts (SOTP) basis and as a prospective takeover target. The stock trades on 6.6 times projected earnings per share for 2010 while the ratio of enterprise value to earnings before interest, tax, depreciation and amortisation is just 4.6. "This is clearly low," the broker argues. "If the share price does not recover then it is possible that Cello could become a target, given the scarcity value of its two operating units. We use a blended SOTP and peer based valuation to derive our 12 month target price, which we set at 71p, indicating over 50% upside," the broker concluded
jeff h
16/9/2010
21:21
Lovely 6 figure buys today. I have added.
santangello
14/9/2010
08:42
Looks like full year profit before tax will be about £6m, putting Cello on a multiple of 5. Peers Creston and Chime rate at 8/9 (even these are low due to market sentiment towards the sector). Debt under control, no earn-outs to come. This should be 75p now, with more value to come for faith in the firm's prospects, sector upgrades and credit for management performance.
coopstock
14/9/2010
08:03
undervalued. suprise no uplift in share price.
maksud
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older
Your Recent History
LSE
CLL
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200128 07:42:26